Description
Description
A 1:1 blend by mass of CJC-1295 (No DAC) and Ipamorelin supplied for controlled research environments. This co-formulation is suitable for studies exploring GHRH-receptor and ghrelin (GHS-R1a)–receptor signaling pathways when evaluated together in model systems.
Composition
-
CJC-1295 (Without DAC): 5 mg
-
Ipamorelin: 5 mg
-
Appearance: Lyophilized powder in a sealed research vial
Research Focus (non-clinical)
-
Comparative and combined pathway evaluation of GHRH analog + GHS agonist in in-vitro or ex-vivo models
-
Assessment of assay development, including chromatographic separation of co-formulated peptides
-
Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions
Documentation
-
COA pending — third-party verification in progress
Important Notice
-
For research use only
-
Not for human consumption
-
Not intended to diagnose, treat, cure, or prevent any disease
Quality & Manufacturing
-
Lot-specific COA (HPLC/LC-MS) with verification key
-
Third-party verification link provided per lot (Janoshik)
-
Lyophilized for transit stability; batch traceable
-
Tamper-evident seal; lot & test date on each vial
-
No MOQ for online orders
-
Bulk orders for physical locations start at 25-unit minimum





Reviews
There are no reviews yet.